Feasibility of Constant Work Rate Testing to Detect Exercise-induced Laryngeal Obstruction

August 15, 2023 updated by: Emil Walsted, Bispebjerg Hospital

TITLE Feasibility of constant work rate testing to detect exercise-induced laryngeal obstruction

DESIGN Prospective observational pilot study

AIMS To investigate if constant work rate testing at different work rates will sufficiently induce detectable exercise-induced laryngeal obstruction (EILO) using CLE.

POPULATION Adult patients with EILO

DURATION 01.09.2022 - 30.06.2023

Study Overview

Study Type

Observational

Enrollment (Estimated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Individuals referred to CLE testing at the asthma service at Bispebjerg Hospital in Copenhagen, Denmark, for the investigation of exercise-related respiratory symptoms, will be offered to participate in the present study in addition to the standard-of-care incremental CLE test.

Al patients will be evaluated during the visit to the asthma service at Bispebjerg Hospital to ensure they are clinically fit for exercise testing.

Description

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 or above with a clinical suspicion of having EILO.
  • Individuals with concurrent asthma can participate in the study provided that their asthma is well-controlled, determined by a negative bronchoprovocation test.

Exclusion Criteria:

  • No EILO found in Clinical standard-of-care CLE test
  • Not able to complete the exercise test for other reasons than breathlessness or leg fatigue (e.g. injury, disease or disability preventing cycling to maximal exertion).
  • Comorbidities other than asthma, which, judged by the investigator, might confound the test results or pose a medical risk to the patient (e.g. cardiac disease, exercise-induced anaphylaxis).
  • Current smokers (< 6 months of stopping) or individuals with a significant smoking history (>10 pack years).
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence and degree of glottic or supraglottic collapse in EILO patients
Time Frame: Changes from baseline during the procedure and immediately after cessation of the exercise test.
Laryngoscopic detection of supraglottic or a glottic obstruction of the same severity as observed during incremental testing, during a submaximal constant work rate exercise test (70 %, 80 % and 90 %) using a visual grade scale (0-3, with 0 reflecting no obstruction, and 3 being the most severe degree of obstruction).
Changes from baseline during the procedure and immediately after cessation of the exercise test.
Time of onset of the laryngeal obstruction
Time Frame: A time of onset determined during the procedures

A specific point in time where observed laryngeal obstruction is first discernible will be determined during the evaluation of the laryngoscopic videos.

This is to descriptively quantify this outcome.

A time of onset determined during the procedures
Observed duration of the laryngeal obstruction
Time Frame: Duration measured in seconds during the procedures
The investigators will further evaluate the laryngoscopic videos and determine the duration of the participant's laryngeal obstruction. This duration is defined as the time period from the time of onset during submaximal exercise, until remission of the observed obstruction or end of the test.
Duration measured in seconds during the procedures

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient reported symptom score: Dyspnoea-12
Time Frame: At baseline
The patients will fill out the Dyspnoea-12 questionnaire before the first exercise test The questionnaire consists of 12 questions regarding dyspnoea. This is a descriptive measure
At baseline
Patient reported symptom scores: Nijmegen
Time Frame: At baseline

The participants will fill out the Nijmegen questionnaire before the first exercise test The questionnaire consists of 16 questions, with answers ranging from "never" to "very often". A score is calculated from these answers. A higher score means that it is more likely that the participant suffers from hyperventilation syndrome.

This is a descriptive measure

At baseline
Patient reported symptom scores: Multidimensional Dyspnoea Profile (MDP).
Time Frame: At baseline

The patients will fill out the Multidimensional Dyspnoea Profile (MDP) questionnaire before the first exercise test This profile consists of questions regarding both affective and sensory components of dyspnoea.

This is a descriptive measure

At baseline
Modified borg dyspnoea during exercise
Time Frame: At baseline and at one minute intervals during the CLE tests (up to 60 minutes)

Minimum score: 0 Maximum score: 10 The participant will be asked to rate dyspnoea at baseline and during the CLE tests at 1 minute intervals.

The investigators will compare the scores between the incremental CLE tests and the constant work rate CLE tests.

At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
Leg fatigue scores during exercise
Time Frame: At baseline and at one minute intervals during the CLE tests (up to 60 minutes)

Minimum score: 0 Maximum score: 10 The participant will be asked to rate leg fatigue at baseline and during the CLE tests at 1 minute intervals.

The investigators will compare the scores between the incremental CLE tests and the constant work rate CLE tests.

At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
Rate of perceived exertion (RPE) scores during exercise
Time Frame: At baseline and at one minute intervals during the CLE tests (up to 60 minutes)

Minimum score: 0 Maximum score: 10 The participant will be asked to evaluate their rate of perceived exertion at baseline and during the CLE tests at 1 minute intervals.

The investigators will compare the scores between the incremental CLE tests and the constant work rate CLE tests.

At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
Inter-rater agreement of the prevalence and degree of glottic or supraglottic collapse in EILO patients
Time Frame: During data analysis (month 1).

After obtaining laryngoscopic video data, the investigators will evaluate the severity of laryngeal obstruction using a visual grade scale (0-3).

From these gradings we will calculate inter-rater agreement values (weighted kappa).

During data analysis (month 1).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2022

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

September 15, 2022

First Submitted That Met QC Criteria

September 23, 2022

First Posted (Actual)

September 28, 2022

Study Record Updates

Last Update Posted (Actual)

August 16, 2023

Last Update Submitted That Met QC Criteria

August 15, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • H-20057391

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise-induced Laryngeal Obstruction (EILO)

Clinical Trials on Continuous laryngoscopy during exercise (CLE), incremental exercise protocol

3
Subscribe